TetraLogic Pharmaceuticals Corp
Change company Symbol lookup
Select an option...
TLOG TetraLogic Pharmaceuticals Corp
JPM-K JPMorgan Chase & Co
KLAC KLA Corp
CNVY Convey Health Solutions Holdings Inc
EBAY eBay Inc
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
Go

Company profile

TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Closing Price
$0.005
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.005
Day's Low
0.005
Volume
(Heavy Day)
Volume:
5,100

10-day average volume:
5,100
5,100

SHAREHOLDER UPDATE: Halper Sadeh LLP Investigates EMCF, MN, FSI, SAIL

9:00 am ET June 6, 2022 (PR Newswire) Print

Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

https://mma.prnewswire.com/media/1553538/Firm_Logo_with_Investor_Law_Firm.jpg

Emclaire Financial Corp. (NASDAQ: EMCF)'s sale to Farmers National Banc Corp. Pursuant to the agreement, Emclaire shareholders may elect to receive either $40.00 per share in cash or 2.15 shares of Farmers' common stock, subject to an overall limitation of 70% of the shares being exchanged for Farmers' shares and 30% for cash. If you are an Emclaire shareholder, click here to learn more about your rights and options.

Manning & Napier, Inc. (NYSE: MN)'s sale to Callodine Group, LLC for $12.85 per share. If you are a Manning & Napier shareholder, click here to learn more about your rights and options.

Flexible Solutions International, Inc. (NYSE: FSI)'s merger with Lygos, Inc. If you are a Flexible Solutions shareholder, click here to learn more about your rights and options.

SailPoint Technologies Holdings, Inc. (NYSE: SAIL)'s sale to Thoma Bravo for $65.25 per share in cash. If you are a SailPoint shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:Halper Sadeh LLPDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com https://www.halpersadeh.com

https://c212.net/c/img/favicon.png?sn=NY79239&sd=2022-06-06

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-update-halper-sadeh-llp-investigates-emcf-mn-fsi-sail-301561498.html

SOURCE Halper Sadeh LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=NY79239&Transmission_Id=202206060900PR_NEWS_USPR_____NY79239&DateId=20220606

comtex tracking

COMTEX_408278489/1005/2022-06-06T09:00:26

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.